Repligen director granted RSUs and stock options
Repligen Corp director Rohin Mhatre reported routine equity compensation awards.
Rhea-AI Filing Summary
Repligen Corp director Rohin Mhatre reported routine equity compensation awards. He received 995 restricted stock units, each representing one share of Repligen common stock, bringing his direct common stock holdings to 5,014 shares after the grant.
He was also granted stock options for 2,239 shares of common stock at an exercise price of $103.38 per share. These options are exercisable starting on May 14, 2027 and expire on May 14, 2036. The restricted stock units and options each vest in full on the earlier of May 14, 2027 or the date of the next annual meeting of shareholders, which has not yet been determined.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 3,234 shares
Grant/Award
2 txns
Insider
Mhatre Rohin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,239 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 995 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,239 contracts (Direct);
Common Stock — 5,014 shares (Direct)
Footnotes (2)
- F1. Mr. Mhatre was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2. Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.
Key Figures
RSU grant: 995 units
Shares held after grant: 5,014 shares
Option grant size: 2,239 options
+3 more
6 metrics
RSU grant
995 units
Restricted stock units awarded to director Rohin Mhatre
Shares held after grant
5,014 shares
Common stock directly held after RSU award
Option grant size
2,239 options
Stock options on common shares granted May 14, 2026
Option exercise price
$103.38 per share
Strike price for 2,239 stock options
Option exercisable date
May 14, 2027
Date options become exercisable
Option expiration
May 14, 2036
Expiration date of stock options
Key Terms
restricted stock units, contingent right, Stock Option (Right to Buy), exercise price, +1 more
5 terms
restricted stock units financial
"Mr. Mhatre was awarded 995 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 103.3800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transaction did Repligen (RGEN) director Rohin Mhatre report?
Director Rohin Mhatre reported routine equity compensation awards. He received 995 restricted stock units and stock options for 2,239 shares of Repligen common stock, all granted at no cash cost to him as part of his director compensation package.
What are the key terms of Rohin Mhatre’s new stock options in Repligen (RGEN)?
Mhatre was granted options on 2,239 shares of Repligen common stock with an exercise price of $103.38 per share. The options become exercisable on May 14, 2027 and expire on May 14, 2036, providing a long-dated equity incentive.
When do Rohin Mhatre’s restricted stock units in Repligen (RGEN) vest?
The 995 restricted stock units vest in full on the earlier of May 14, 2027 or the date of Repligen’s next annual shareholder meeting. That meeting date has not yet been determined, so vesting could occur sooner if the meeting is held before May 14, 2027.
Are Rohin Mhatre’s awards in Repligen (RGEN) cash or equity based?
Both awards are equity-based. The 995 restricted stock units can only be settled in shares of Repligen common stock, and the 2,239 stock options give a right to buy shares at $103.38. No cash compensation figures appear in this Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
